Description

MDMB-CHMINACA (also known as MDMB(N)-CHM) is an indazole-based synthetic cannabinoid that acts as a potent agonist of the CB1 receptor, and has been sold online as a designer drug. It was invented by Pfizer in 2008, and is one of the most potent cannabinoid agonists known, with a binding affinity of 0.0944 nM at CB1, and an EC50 of 0.330 nM. It is closely related to MDMB-FUBINACA, which caused at least 1000 hospitalizations and 40 deaths in Russia as consequence of intoxication

Additional Information
Product name

Chemical Name

N-​[[1-​(cyclohexylmethyl)-​1H-​indazol-​3-​yl]carbonyl]-​3-​methyl-​L-​valine

CAS

1185888-32-7

ChemSpider Number

32055574

PubChem CID

121491808

Formula

C22H31N3O3

Molar mass

385.51 g·mol−1

Purity

≥ 99%

Stability

2 Years

Storage

-20°

1 review for MDMB-CHMINACA
  1. person By Robert access_time Published on

    Excellent seller – fast shipping, well packed, very pure. Thank you!

    5 out of 5
Add a review